EQUITY RESEARCH MEMO

ProMed Molding

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)70/100

ProMed Molding is a contract manufacturer specializing in complex molded silicone and plastic components for highly regulated markets, including drug delivery and medical devices. With over 30 years of experience, the company offers end-to-end services from prototype development through production, emphasizing design for manufacturability, material selection, and cost-effective solutions. Its expertise in precision molding positions it as a key partner for pharmaceutical and medical device companies developing drug-device combination products. As the trend toward self-administration and complex biologics grows, demand for advanced delivery systems is rising. ProMed's established capabilities and regulatory compliance make it well-positioned to capture new contracts. The company operates out of Santa Ana, California, and serves a stable customer base in the life sciences sector.

Upcoming Catalysts (preview)

  • Q4 2026New contract with top-10 pharma for drug delivery component60% success
  • Q2 2026Expansion of Class 8 cleanroom manufacturing capacity80% success
  • Q3 2026Achievement of ISO 13485:2016 certification renewal95% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)